These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8317005)

  • 1. [Gene mutation in bladder cancer. Towards molecular pathology].
    Olsen S
    Ugeskr Laeger; 1993 May; 155(21):1648-9. PubMed ID: 8317005
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations of RAS gene family in specimens of bladder cancer.
    Karimianpour N; Mousavi-Shafaei P; Ziaee AA; Akbari MT; Pourmand G; Abedi A; Ahmadi A; Afshin Alavi H
    Urol J; 2008; 5(4):237-42. PubMed ID: 19101897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of bladder cancer: pathways of development and progression.
    Knowles MA
    Cancer Surv; 1998; 31():49-76. PubMed ID: 15281317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low incidence of mutations in codon 12 of the c-K-ras gene in bladder cancer].
    Ejarque MJ; Villanueva A; Chechile G; Regalado R; Errando C; Algaba F; Capella G; Lluis F; Villavicencio H; Vicente J
    Actas Urol Esp; 1995 Sep; 19(8):599-603. PubMed ID: 8669326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
    Sugano K; Kakizoe T
    Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetic markers in bladder cancer].
    Chéchile-Toniolo GE
    Actas Urol Esp; 1994 May; 18(5):549-51. PubMed ID: 8079677
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of bladder cancer gene and relevant molecular biology should be strengthened].
    Li CL; Han SJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):793-4. PubMed ID: 17565855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
    Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of p53 gene mutation in human bladder cancer].
    Ding Q; Zhang Y; Sun X
    Zhonghua Wai Ke Za Zhi; 1995 Nov; 33(11):684-6. PubMed ID: 8731915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
    Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
    Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to quantitatively detect H-ras point mutation based on electrochemiluminescence.
    Zhu D; Xing D; Shen X; Liu J
    Biochem Biophys Res Commun; 2004 Nov; 324(2):964-9. PubMed ID: 15474521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-ras immunohistochemical expression and molecular analysis of urinary bladder lesions in grazing adult cattle exposed to bracken fern.
    Sardon D; de la Fuente I; Calonge E; Perez-Alenza MD; Castaño M; Dunner S; Peña L
    J Comp Pathol; 2005; 132(2-3):195-201. PubMed ID: 15737346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
    Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
    J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?
    Shinohara N; Koyanagi T
    Urol Res; 2002 Oct; 30(5):273-81. PubMed ID: 12389114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene amplification in bladder tumors].
    Pinto MC; de Carvalho AP
    Actas Urol Esp; 1997; 21(10):942-9. PubMed ID: 9494156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymerase beta gene mutations in human bladder cancer.
    Matsuzaki J; Dobashi Y; Miyamoto H; Ikeda I; Fujinami K; Shuin T; Kubota Y
    Mol Carcinog; 1996 Jan; 15(1):38-43. PubMed ID: 8561864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis.
    Gao J; Huang HY; Pak J; Cheng J; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
    Oncogene; 2004 Jan; 23(3):687-96. PubMed ID: 14737103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.